Skip to Main Content

Paper Details

CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies.
Clin Cancer Res
33
2020
Author NameAffiliation
Peter A KienerBioKien LLC
Steven C AlmoAlbert Einstein College of Medicine
Ronald D Seidel
Kenneth J PientaThe Brady Urological Institute, Johns Hopkins University School of Medicine
  • 1 - 4

Datasets

Release 1.2